Some of these variants are located in or nearby genes that are frequently altered by mutations and/or aberrant expression in the tumor, such as EGFR, CDKN2A/B, TERT, and TP53. Although the associations reported by GWAS are in many cases well established by replication in multiple studies, the mechanisms of action of these variants are generally poorly understood. Here, EGFR is linked to neoplasm.